These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14341030)

  • 1. ATROPHIC AND SENILE VAGINO-PERINEAL DISORDERS: NEW TREATMENT WITH AN ESTROGEN-PROGESTERONE VAGINAL CREAM.
    KARNAKY KJ
    J Am Geriatr Soc; 1965 Sep; 13():820-7. PubMed ID: 14341030
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the Effects of Fenugreek Vaginal Cream and Ultra Low- Dose Estrogen on Atrophic Vaginitis.
    Safary M; Hakimi S; Mobaraki-Asl N; Amiri P; Tvassoli H; Delazar A
    Curr Drug Deliv; 2020; 17(9):815-822. PubMed ID: 32640956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATROPHIC OR SENILE VAGINITIS: TREATMENT WITH DIENESTROL CREAM.
    FALK HC; HASSID R
    J Am Geriatr Soc; 1963 Dec; 11():1152-7. PubMed ID: 14102837
    [No Abstract]   [Full Text] [Related]  

  • 4. NITROFURAZONE-ESTROGEN VAGINAL SUPPOSITORIES IN THE TREATMENT OF ATROPHIC VAGINITIS.
    FRIEDMAN JA; OLSEN N
    J Am Geriatr Soc; 1965 Sep; 13():828-31. PubMed ID: 14341031
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaginal estrogen therapy for the treatment of atrophic vaginitis.
    Lynch C
    J Womens Health (Larchmt); 2009 Oct; 18(10):1595-606. PubMed ID: 19788364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aloe Vera; A new treatment for atrophic vaginitis, A randomized double-blinded controlled trial.
    Poordast T; Ghaedian L; Ghaedian L; Najib FS; Alipour S; Hosseinzadeh M; Vardanjani HM; Salehi A; Hosseinimehr SJ
    J Ethnopharmacol; 2021 Apr; 270():113760. PubMed ID: 33383112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma estrogen concentrations after oral and vaginal estrogen administration in women with atrophic vaginitis.
    Dorr MB; Nelson AL; Mayer PR; Ranganath RP; Norris PM; Helzner EC; Preston RA
    Fertil Steril; 2010 Nov; 94(6):2365-8. PubMed ID: 20466363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated estrogens (Premarin) vaginal cream.
    Med Lett Drugs Ther; 2009 Feb; 51(1306):14-5. PubMed ID: 19229162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ovestin cream in the treatment of postmenopausal vulvovaginal atrophy and atrophic vaginitis].
    Grcić R; Stavrić V; Knezević A; Kadija D; Perisić Z
    Med Pregl; 1987; 40(1-2):65-72. PubMed ID: 3657725
    [No Abstract]   [Full Text] [Related]  

  • 10. Atrophic vaginitis.
    Stika CS
    Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen therapy in atrophic vaginitis.
    Kyriazis GA; Balin H
    Pa Med; 1970 Dec; 73(12):32-4. PubMed ID: 5480497
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of micronized estradiol vaginal cream.
    Gordon WE; Hermann HW; Hunter DC
    South Med J; 1979 Oct; 72(10):1252-3, 1258. PubMed ID: 482979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.
    Bachmann G; Bouchard C; Hoppe D; Ranganath R; Altomare C; Vieweg A; Graepel J; Helzner E
    Menopause; 2009; 16(4):719-27. PubMed ID: 19436223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of vaginal estrogen cream and sustained-release estradiol vaginal tablet (Vagifem) in the treatment of atrophic vaginitis in Isfahan, Iran in 2010-2012.
    Hosseinzadeh P; Ghahiri A; Daneshmand F; Ghasemi M
    J Res Med Sci; 2015 Dec; 20(12):1160-5. PubMed ID: 26958050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic and cytologic effects of vaginal estrogen in women with pelvic organ prolapse: a randomized controlled trial.
    Vaccaro CM; Mutema GK; Fellner AN; Crisp CC; Estanol MV; Kleeman SD; Pauls RN
    Female Pelvic Med Reconstr Surg; 2013; 19(1):34-9. PubMed ID: 23321657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermatologic causes of vaginitis: a clinical review.
    Edwards L
    Dermatol Clin; 2010 Oct; 28(4):727-35. PubMed ID: 20883916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal estrogen creams: use patterns among a cohort of women.
    Keenan NL; Franks AL; Croft JB; Scholes D; Murray ET
    J Am Geriatr Soc; 1999 Jan; 47(1):65-70. PubMed ID: 9920231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic absorption and sustained effects of vaginal estrogen creams.
    Martin PL; Yen SS; Burnier AM; Hermann H
    JAMA; 1979 Dec; 242(24):2699-700. PubMed ID: 228093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Women's preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy.
    Mattsson LÅ; Ericsson Å; Bøgelund M; Maamari R
    Maturitas; 2013 Mar; 74(3):259-63. PubMed ID: 23312488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
    Crandall C
    J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.